Chemical determinants of antimalarial activity of reversed siderophores

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2160-2166

  Tsafack, A ^a   Libman, J ^b   Shanzer, A ^b   Cabantchik, Z I ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; ESTERASE; FERRICHROME; SCAVENGER; SIDEROPHORE;

ANTIMALARIAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; ERYTHROCYTE GHOST; ERYTHROCYTE MEMBRANE; IRON CHELATION; IRON KINETICS; IRON STORAGE; NONHUMAN; PARASITE DEVELOPMENT; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0029792973     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2160     Document Type: Article

References (35)

1. Atamna, H., and H. Ginsburg. 1995. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J. Biol. Chem. 270:24876-24883.
2. Breuer, W., S. Epsztejn, P. Millgram, and Z. I. Cabantchik. 1995. Transport of iron and other transition metals into cells as revealed by fluorescent probe. Am. J. Physiol. 268:C1354-C1361.
3. Bunnag, D., A. A. Poltera, A. Viravan, S. Looareesuwan, K. T. Harinasuta, and C. Schindlery. 1992. Plasmocidal effect of desferrioxamine B in human vivax or falciparum malaria from thailand. Acta Trop. 52:59-67.
4. Cabantchik, Z. I. 1995. Iron chelators as antimalarials: the biochemical basis of selective cytotoxicity. Parasitol. Today 11:74-78.
5. Cabantchik, Z. I., H. Glickstein, J. Golenser, M. Loyevsky, and A. Tsafack. 1996. Iron chelators. Mode of action as antimalarials. Acta Haematol. 95: 70-77.
6. Cabantchik, Z. I., H. Glickstein, P. Milgram, and W. Breuer. 1996. A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells. Anal. Biochem. 233:221-227.
7. Ceriotti, F., and G. Ceriotti. 1980. Improved direct specific determination of serum iron and total iron-binding capacity. Clin. Chem. 26:327-331.
8. Dayan, I., J. Libman, Y. Agi, and A. Shanzer. 1993. Chiral siderophore analogs: ferrichrome. Inorg. Chem. 32:1467-1475.
9. 2+ binding. J. Am. Chem. Soc. 113:3431-3439.
10. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
11. Fritsch, G., J. Treumer, D. T. Spira, and A. Jung. 1985. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp. Parasitol. 60:171-174.
12. Gabay, T., and H. Ginsburg. 1993. Hemoglobin denaturation and iron release in acidified red blood cell lysate: a possible source of iron for intraerythrocytic malaria parasites. Exp. Parasitol. 77:261-272.
13. Golenser, J., A. Tsafack, Y. Amichai, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1995. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrob. Agents Chemother. 39:61-65.
14. Gordeuk, V. R., G. M. Brittenham, and P. E. Thuma. 1994. Iron chelation as a chemotherapeutic strategy in the treatment of malaria, p. 111-130. In R. J. Bergeron and G. M. Brittenham (ed.), The development of iron chelators for clinical use. CRC Press, Inc., Boca Raton, Fla.
15. Heppner, D. G., P. E. Hallaway, G. J. Kontoghiorghes, and J. W. Eaton. 1988. Antimalarial properties of orally active iron chelators. Blood 72:358-361.
16. Hershko, C., and T. E. A. Peto. 1988. Deferoxamine inhibition of malaria is independent of host iron status. J. Exp. Med. 168:375-387.
17. Loyevsky, M., S. D. Lytton, B. Mester, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1993. The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J. Clin. Invest. 91:218-224.
18. Lytton, S. D., M. Loyevsky, B. Mester, J. Libman, I. Landau, A. Shanzer, and Z. I. Cabantchik. 1993. In vivo amimalarial action of a lipophilic iron (III) chelator: suppression of Plasmodium vinckei infection by reversed siderophore. Am. J. Hematol. 43:217-220.
19. Lytton, S. D., B. Mester, I. Dayan, H. Glickstein, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1993. Mode of action of iron (III) chelators as antimalarials. I. Membrane permeation properties and cytotoxic activity. Blood 81: 214-221.
20. Lytton, S. D., B. Mester, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1994. Mode of action of iron (III) chelators as antimalarials. II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood 84:910-915.
21. Poch, G. 1993. Combined effects of drugs and toxic agents. Modern evaluation in theory and practice. Springer-Verlag, New York.
22. Pollack, S., R. N. Rossan, D. E. Davidson, and A. Escjadillo. 1987. Desferrioxamine suppresses Plasmodium falciparum in aotus monkeys. Proc. Soc. Exp. Biol. Med. 184:162-167.
23. Raventos-Suarez, C., S. Pollack, and R. L. Nagel. 1980. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am. J. Trop. Med. Hyg. 31:919-922.
24. Rivadeneira, E. M., M. Wasserman, and C. Espinal. 1983. Separation and concentration of schizonts of Plasmodium falciparum by Percoll gradients. J. Protozool. 30:367-370.
25. 59Fe in Plasmodium falciparum in the presence of oxines, p. 119-149. In G. Brewer (ed.), Malaria and the red cell. Alan R. Liss, Inc., New York.
26. Scott, M. D., A. Ranz, F. A. Kuypers, B. H. Lubin, and S. R. Meshnick. 1990. Parasite uptake of deferroxamine: a prerequisite for antimalarial activity. Br. J. Haematol. 75:598-602.
27. Shanzer, A., and J. Libman. 1991. Biomimetic siderophores, p. 309-338. In G. Winkelmann (ed.), CRC Handbook of Microbial Iron Chelates. CRC Press, Inc., Boca Raton, Fla.
28. Shanzer, A., J. Libman, S. D. Lytton, H. Glickstein, and Z. I. Cabantchik. 1989. Reversed siderophores act as antimalarial agents. Proc. Natl. Acad. Sci. USA 88:6585-6589.
29. Trager, W., and J. B. Jensen. 1976. Continuous culture of human malaria parasites. Science 193:673-675.
30. Traore, O., P. Carnevalle, L. Kaptue-Noche, J. M'Nbede, M. Desfontaine, J. Elion, D. Labie, and R. Nagel. 1991. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am. J. Hematol. 37:206-208.
31. Tsafack, A., J. Golenser, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1995. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol. Pharmacol. 47:403-409.
32. Tsafack, A., M. Loyevsky, P. Ponka, and Z. I. Cabantchik. 1996. Mode of action of iron(III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives. J. Lab. Clin. Med. 127:574-582.
33. Wyler, D. J. 1992. Bark, weeds, and iron chelators - drugs for malaria. N. Engl. J. Med. 327:1519-1521.
34. Yakirevitch, P., N. Rochel, A. M. Albrecht-Gary, J. Libman, and A. Shanzer. 1991. Chiral siderophore analogs: ferrioxamines and their iron(III) coordination properties. Inorg. Chem. 32:3431-3439.
35. Zanninelli, G., H. Glickstein, W. Breuer, P. Milgram, P. Brissot, R. C. Hider, A. M. Konijn, J. Libman, A. Shanzer, and Z. I. Cabantchik. Submitted for publication.